table of content
1 Introduction to Research & Analysis Reports
1.1 Dermatological OTC Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global Dermatological OTC Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dermatological OTC Drugs Overall Market Size
2.1 Global Dermatological OTC Drugs Market Size: 2021 VS 2028
2.2 Global Dermatological OTC Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dermatological OTC Drugs Players in Global Market
3.2 Top Global Dermatological OTC Drugs Companies Ranked by Revenue
3.3 Global Dermatological OTC Drugs Revenue by Companies
3.4 Top 3 and Top 5 Dermatological OTC Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dermatological OTC Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dermatological OTC Drugs Players in Global Market
3.6.1 List of Global Tier 1 Dermatological OTC Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Dermatological OTC Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Dermatological OTC Drugs Market Size Markets, 2021 & 2028
4.1.2 Acne Medications
4.1.3 Dermatitis Drugs
4.1.4 Fungal Infection Drugs
4.2 By Type - Global Dermatological OTC Drugs Revenue & Forecasts
4.2.1 By Type - Global Dermatological OTC Drugs Revenue, 2017-2022
4.2.2 By Type - Global Dermatological OTC Drugs Revenue, 2023-2028
4.2.3 By Type - Global Dermatological OTC Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dermatological OTC Drugs Market Size, 2021 & 2028
5.1.2 Online Distribution
5.1.3 Offline Distribution
5.2 By Distribution Channel - Global Dermatological OTC Drugs Revenue & Forecasts
5.2.1 By Distribution Channel - Global Dermatological OTC Drugs Revenue, 2017-2022
5.2.2 By Distribution Channel - Global Dermatological OTC Drugs Revenue, 2023-2028
5.2.3 By Distribution Channel - Global Dermatological OTC Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Dermatological OTC Drugs Market Size, 2021 & 2028
6.2 By Region - Global Dermatological OTC Drugs Revenue & Forecasts
6.2.1 By Region - Global Dermatological OTC Drugs Revenue, 2017-2022
6.2.2 By Region - Global Dermatological OTC Drugs Revenue, 2023-2028
6.2.3 By Region - Global Dermatological OTC Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Dermatological OTC Drugs Revenue, 2017-2028
6.3.2 US Dermatological OTC Drugs Market Size, 2017-2028
6.3.3 Canada Dermatological OTC Drugs Market Size, 2017-2028
6.3.4 Mexico Dermatological OTC Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Dermatological OTC Drugs Revenue, 2017-2028
6.4.2 Germany Dermatological OTC Drugs Market Size, 2017-2028
6.4.3 France Dermatological OTC Drugs Market Size, 2017-2028
6.4.4 U.K. Dermatological OTC Drugs Market Size, 2017-2028
6.4.5 Italy Dermatological OTC Drugs Market Size, 2017-2028
6.4.6 Russia Dermatological OTC Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Dermatological OTC Drugs Market Size, 2017-2028
6.4.8 Benelux Dermatological OTC Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Dermatological OTC Drugs Revenue, 2017-2028
6.5.2 China Dermatological OTC Drugs Market Size, 2017-2028
6.5.3 Japan Dermatological OTC Drugs Market Size, 2017-2028
6.5.4 South Korea Dermatological OTC Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Dermatological OTC Drugs Market Size, 2017-2028
6.5.6 India Dermatological OTC Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Dermatological OTC Drugs Revenue, 2017-2028
6.6.2 Brazil Dermatological OTC Drugs Market Size, 2017-2028
6.6.3 Argentina Dermatological OTC Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dermatological OTC Drugs Revenue, 2017-2028
6.7.2 Turkey Dermatological OTC Drugs Market Size, 2017-2028
6.7.3 Israel Dermatological OTC Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Dermatological OTC Drugs Market Size, 2017-2028
6.7.5 UAE Dermatological OTC Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Perrigo Company plc
7.1.1 Perrigo Company plc Corporate Summary
7.1.2 Perrigo Company plc Business Overview
7.1.3 Perrigo Company plc Dermatological OTC Drugs Major Product Offerings
7.1.4 Perrigo Company plc Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.1.5 Perrigo Company plc Key News
7.2 Bausch Health Companies Inc.
7.2.1 Bausch Health Companies Inc. Corporate Summary
7.2.2 Bausch Health Companies Inc. Business Overview
7.2.3 Bausch Health Companies Inc. Dermatological OTC Drugs Major Product Offerings
7.2.4 Bausch Health Companies Inc. Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.2.5 Bausch Health Companies Inc. Key News
7.3 Dr. Reddy's Laboratories
7.3.1 Dr. Reddy's Laboratories Corporate Summary
7.3.2 Dr. Reddy's Laboratories Business Overview
7.3.3 Dr. Reddy's Laboratories Dermatological OTC Drugs Major Product Offerings
7.3.4 Dr. Reddy's Laboratories Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.3.5 Dr. Reddy's Laboratories Key News
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Corporate Summary
7.4.2 Johnson and Johnson Business Overview
7.4.3 Johnson and Johnson Dermatological OTC Drugs Major Product Offerings
7.4.4 Johnson and Johnson Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.4.5 Johnson and Johnson Key News
7.5 Bayer AG
7.5.1 Bayer AG Corporate Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Dermatological OTC Drugs Major Product Offerings
7.5.4 Bayer AG Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.5.5 Bayer AG Key News
7.6 GlaxoSmithKline plc.
7.6.1 GlaxoSmithKline plc. Corporate Summary
7.6.2 GlaxoSmithKline plc. Business Overview
7.6.3 GlaxoSmithKline plc. Dermatological OTC Drugs Major Product Offerings
7.6.4 GlaxoSmithKline plc. Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline plc. Key News
7.7 Viatris Inc
7.7.1 Viatris Inc Corporate Summary
7.7.2 Viatris Inc Business Overview
7.7.3 Viatris Inc Dermatological OTC Drugs Major Product Offerings
7.7.4 Viatris Inc Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.7.5 Viatris Inc Key News
7.8 LEO Pharma A/S
7.8.1 LEO Pharma A/S Corporate Summary
7.8.2 LEO Pharma A/S Business Overview
7.8.3 LEO Pharma A/S Dermatological OTC Drugs Major Product Offerings
7.8.4 LEO Pharma A/S Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.8.5 LEO Pharma A/S Key News
7.9 Acella Pharmaceuticals, LLC
7.9.1 Acella Pharmaceuticals, LLC Corporate Summary
7.9.2 Acella Pharmaceuticals, LLC Business Overview
7.9.3 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Major Product Offerings
7.9.4 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.9.5 Acella Pharmaceuticals, LLC Key News
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.10.3 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.10.5 Teva Pharmaceutical Industries Ltd. Key News
7.11 Galderma
7.11.1 Galderma Corporate Summary
7.11.2 Galderma Business Overview
7.11.3 Galderma Dermatological OTC Drugs Major Product Offerings
7.11.4 Galderma Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.11.5 Galderma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
